Abstract
Since bisphenol F (4,4’-dihydroxydiphenylmethane) has been reported to exhibit estrogen agonistic properties in the uterotrophic assay, we performed a 28-day repeated-dose toxicity study (enhanced OECD test guideline No. 407) on bisphenol F based on the OECD draft protocols to determine whether it has endocrine-mediated properties. Bisphenol F was orally administered at doses 0, 20, 100 and 500 mg/kg per day for at least 28 days, but no clear endocrine-mediated changes were detected, and it was concluded to have no endocrine-mediated effects in young adult rats. On the other hand, the main effect of bisphenol F was concluded to be liver toxicity based on clinical biochemical parameters and liver weight, but without histopathological changes. The no-observed-effect level for bisphenol F is concluded to be under 20 mg/kg per day since decreased body weight accompanied by decreased serum total cholesterol, glucose, and albumin values were observed in the female rats given 20 mg/kg per day or higher doses of bisphenol F.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Andrews P, Freyberger A, Hartmann E, Eiben R, Loof I, Schmidt U, Temerowski M, Becka M (2001) Feasibility and potential gains of enhancing the subacute rat study protocol (OECD test guideline no. 407) by additional parameters selected to determine endocrine modulation. A pre-validation study to determine endocrine-mediated effects of the antiandrogenic drug flutamide. Arch Toxicol 75:65–73
Ching M (1981) Effect of barbital on the pituitary–thyroid axis. J Endocrinol Invest 4:389–392
Gelbke HP, Hofmann A, Owens JW, Freyberger A (2007) The enhancement of the subacute repeat dose toxicity test OECD TG 407 for the detection of endocrine active chemicals: comparison with toxicity tests of longer duration. Arch Toxicol 81:227–250
Kennel P, Pallen C, Barale-Thomas E, Espuna G, Bars R (2003) Tamoxifen: 28-day oral toxicity study in the rat based on the enhanced OECD test guideline 407 to detect endocrine effects. Arch Toxicol 77:487–489
Kunimatsu T, Yamada T, Miyata K, Yabushita S, Seki T, Okuno Y, Matsuo M (2004) Evaluation for reliability and feasibility of the draft protocol for the enhanced rat 28-day subacute study (OECD guideline 407) using androgen antagonist flutamide. Toxicology 2000:77–89
Mellert W, Deckardt K, Walter J, Gfatter S, van Ravenzwaay B (2003) Detection of endocrine-modulating effects of the antithyroid acting drug 6-propyl-2-thiouracil in rats, based on the “enhanced OECD test guideline 407”. Regul Toxicol Pharmacol 38:368–377
Miyata K, Shiraishi S, Houshuyama S, Imatanaka N, Umano T, Minobe Y, Yamasaki K (2006) Subacute oral toxicity study of di(2-ethylhexyl)adipate based on the draft protocol for the “Enhanced OECD Test Guideline no. 407”. Arch Toxicol 80:181–186
OECD (1999) EMSG OECD draft proposal for testing of adequacy of an enhanced OECD protocol, repeated dose (28 days) toxicity (oral) study, based on OECD 407, OECD, Paris
OECD (2000) OECD protocol for investigating the efficacy of the enhanced TG407 test guideline (phase 2), rationale for the investigation, and description of the protocol, OECD, Paris
OECD (2001) Third meeting of the validation management group for the screening and testing of endocrine disrupters (mammalian effects), OECD, Paris
OECD (2006) OECD 5th meeting of the validation management group for mammalian effects testing (vmg-mammalian) of the task force on endocrine disrupters testing and assessment, OECD, Washington
OECD (2007) OECD 6th meeting of the validation management group for mammalian effects testing (vmg-mammalian) of the task force on endocrine disrupters testing and assessment, OECD, Ljubljana
Okazaki K, Okazaki S, Nishimura S, Nakamura H, Kitamura Y, Hatayama K, Nakamura A, Tsuda T, Katsumata T, Nishikawa A, Hirose M (2001) A repeated 28-day oral dose toxicity study of methoxychlor in rats, based on the ‘enhanced OECD test guideline 407’ for screening endocrine-disrupting chemicals. Arch Toxicol 75:513–521
Okazaki K, Imazawa T, Nakamura H, Furukawa F, Nishikawa A, Hirose M (2002a) A repeated 28-day oral dose toxicity study of 17α-methyltestosterone in rats, based on the ‘enhanced OECD test guideline 407’ for screening endocrine-disrupting chemicals. Arch Toxicol 75:635–642
Okazaki K, Okazaki S, Nakamura H, Kitamura Y, Hatayama K, Wakabayashi S, Tsuda T, Katsumata T, Nishikawa A, Hirose M (2002b) A repeated 28-day oral dose toxicity study of genisein in rats, based on the ‘enhanced OECD test guideline 407’ for screening endocrine-disrupting chemicals. Arch Toxicol 76:553–559
Shin JH, Moon HJ, Kim TS, Kang IH, Kim HY, Choi KS, Han SY (2006a) Repeated 28-day oral toxicity study of vinclozolin in rats based on the draft protocol for the “Enhanced OECD Test Guideline No. 407” to detect endocrine effects. Arch Toxicol 80:547–554
Shin JH, Moon HJ, Kang IH, Kim TS, Kim IY, Park IS, Kim HS, Jeung EB Han SY (2006b) Repeated 28-day oral toxicity study of ketoconazole in rats based on the draft protocol for the “Enhanced OECD Test Guideline No. 407” to detect endocrine effects. Arch Toxicol 80:797–803
Shiraishi K, Miyata K, Houshuyama S, Imatanaka N, Umano T, Minobe Y, Yamasaki K (2006) Subacute oral toxicity study of diethylphthalate based on the draft protocol for “Enhanced OECD Test Guideline no. 407”. Arch Toxicol 80:10–16
Toyoda K, Shibuntani M, Tamaru T, Koujitani T, Uneyama C, Hirose M (2000) Repeated dose (28 days) oral toxicity study of flutamide in rats, based on the draft protocol for the ‘enhanced OECD test guideline 407’ for screening for endocrine-disrupting chemicals. Arch Toxicol 74:127–132
Valle LB, Oliveria-Filho RM, Romaldini JH, Lara PF (1985) Pituitary-testicular axis abnormalities in immature male hypothyroid rats. J Steroid Biochem 23:253–257
Wason S, Pohlmeyer-Esch G, Pallen C, Palazzi X, Espina G, Bars R (2003) 17α-methyltestosterone: 28-day oral toxicity study in the rat based on the “enhanced OECD test guideline 407” to detect endocrine effects. Toxicology 192:119–137
Woo GH, Shibutani M, Ichiki T, Hamamura M, Lee KY, Inoue K, Hirose M A (2007) Repeated 28-day oral dose toxicity study of nonylphenol in rats, based on the ‘Enhanced OECD Test Guideline 407’ for screening of endocrine-disrupting chemicals. Arch Toxicol 81:77–88
Yamasaki K, Tago Y, Nagai K, Sawaki M, Noda S, Takatsuki M (2002a) Comparison of toxicity studies based on the draft protocol for the “enhanced OECD test guideline no. 407” and the research protocol of “pubertal development and thyroid function in immature male rats” with 6-n-propyl-2-thiouracil. Arch Toxicol 76:495–501
Yamasaki K, Sawaki M, Noda S, Imatanaka M, Takatsuki M (2002b) Subacute oral toxicity study of ethynyl estradiol and bisphenol A based on the draft protocol for the “enhanced OECD test guideline no. 407”. Arch Toxicol 76:65–74
Yamasaki K, Takeyoshi M, Yakabe Y, Sawaki M, Imatanaka M, Takatsuki M (2002c) Comparison of reporter gene assay and immature rat uterotrophic assay of twenty-three chemicals. Toxicology 170:21–30
Yamasaki K, Takeyoshi M, Yakabe Y, Sawaki M, Imatanaka M, Shinoda K, Takatsuki M (2003) Immature rat uterotrophic assay of 18 chemicals and Hershberger assay of 30 chemicals. Toxicology 183:95–115
Acknowledgments
This work was supported by a grant from Ministry of Economical Trade and Industry.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Higashihara, N., Shiraishi, K., Miyata, K. et al. Subacute oral toxicity study of bisphenol F based on the draft protocol for the “Enhanced OECD Test Guideline no. 407”. Arch Toxicol 81, 825–832 (2007). https://doi.org/10.1007/s00204-007-0223-4
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00204-007-0223-4